Both perimenstrual and non-perimenstrual migraine days respond to anti-calcitonin gene-related peptide (receptor) antibodies.

Iris Elsa Verhagen Simone de Vries LentschBritt W H van der ArendSaskia le CessieAntoinette MaassenVanDenBrinkGisela M Terwindt

Published in: European journal of neurology (2023)

Our findings support prophylactic use of anti-CGRP (receptor) antibodies for women with menstrual migraine as this leads to consistent reductions in number of migraine days during the entire menstrual cycle.

Keyphrases

genome wide
copy number
gene expression
binding protein
dna methylation
transcription factor
genome wide identification